Baby Formula Emergency Act

United States117th CongressHR-7822House of Representatives
Updated: May 18, 2022

Summary

Baby Formula Emergency Act This bill authorizes the President, during an infant formula shortage or potential shortage, to allow the production and marketing or duty-free importation of infant formula that meets specified criteria, regardless of Food and Drug Administration (FDA) requirements. The criteria include that the United States has not imposed any sanctions with respect to the manufacturer of the formula and the FDA has not determined that such formula is unsafe. Further, the President must notify Congress about determinations related to supply shortages of infant formula.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the Subcommittee on Trade.

    House of Representatives

  2. Introduced in House

  3. Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

All available records shown.